Clinical Trial Update: Study for HER2-Overexpressed MBC Patients Treated by Cipterbin® Plus vinorelbinE

View source ↗

Summary

A completed trial evaluating Cipterbin plus vinorelbine in HER2-positive metastatic breast cancer, reporting progression-free survival, overall response rate, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Cipterbin
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Shanghai CP Guojian Pharmaceutical Co., Ltd. | Conditions: Progress-free Survival, Overall Response Rate | Status: COMPLETED